Protein-Serine-Threonine Kinases, antagonists & inhibitors

All categories
Name
Protein-Serine-Threonine Kinases, antagonists & inhibitors
Accession Number
DBCAT001670  (DBCAT005542)
Description

Not Available

Drugs
DrugDrug Description
TanespimycinInvestigated for use/treatment in leukemia (myeloid) and solid tumors.
RetaspimycinInvestigated for use/treatment in gastric cancer, lung cancer, and multiple myeloma.
N-chlorotaurineInvestigated for use/treatment in eye disorders/infections.
IPI-493IPI-493 has been used in trials studying the treatment of Advanced Malignancies.
Drugs & Drug Targets
DrugTargetType
TanespimycinHeat shock protein HSP 90-alphatarget
TanespimycinHeat shock protein HSP 90-betatarget
TanespimycinSerum albumincarrier